Post by
Kingpin68 on Jun 20, 2024 8:21am
Increased Value
In this latest release, they did not state if the combination of R and the non cancer drug was better than R alone. Are the non cancer drugs just riding the coat tails of R ? Either way, the patents held by Theralase keep increasing in value many times over in my opinion. I think they will make it to approval, but even in a worst case scenario, the patent portfolio must be worth $1-$2 share, or more ?
It's a no brainer.
Comment by
Alamir1111 on Jun 20, 2024 9:45am
I guess they're just waiting on biostatistics organization to prove their theory or effectiveness